Barc et al. studied type 2 diabetes patients with critical limb ischemia, using an intramuscular injection of pIRES/VEGF165/HGF bicistronic plasmid (plasmid internal ribosome entry site/vascular endothelial growth factor 165/hepatocyte growth factor). This evidence concerns the gene HGF and type 2 diabetes mellitus.